ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 355,37
1,00%
Dow Jones
42 992,21
-0,77%
DAX
19 984,32
0,74%
Brent Oil
73,44
0,00%
Bitcoin
94 470,98
0,33%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. USOTC

  6. Defence Therapeutics Inc (QB) (DTCFF) Cours

Defence Therapeutics Inc (QB)

Defence Therapeutics Inc (QB) (DTCFF)

USOTC
0,4558
0,1826
(66,84%)
Fermé 28 Décembre 10:00PM
Retardé de 15 minutes

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Premium

Statistiques et détails clés

Dernier
0,4558
Prix Achat
0,1457
Prix Vente
0,7813
Volume échangé
3 358
0,39 Fourchette du Jour 0,4558
0,2732 Plage de 52 semaines 1,738
Cap du marché
21,719M
Clôture Veille
0,2732
Ouverture
0,39
Dernière Transaction
358
@
0.4558
Dernière heure de transaction
Volume financier
US$ 1 333
VWAP
0,397015
Volume moyen (3 m)
679
Actions en circulation
47 650 370
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-1,66
Bénéfice par action (BPA)
-0,28
Chiffre d'affairess
-
Bénéfice net
-13,19M

À propos de Defence Therapeutics Inc (QB)

Secteur
Pharmaceutical Preparations
Industrie
Pharmaceutical Preparations
Site Web
www.defencetherapeutics.com
Siège social
Vancouver, British Columbia, Can
Fondé
-
Defence Therapeutics Inc (QB) est coté dans le secteur Pharmaceutical Preparations de la OTCMarkets avec le ticker DTCFF. Le dernier cours de clôture d'Defence Therapeutics (QB) était de US$0,27. Au cours de la dernière année, les actions de Defence Therapeutics (QB) ont été négociées dans une fourchette de prix de US$ 0,2732 à US$ 1,738.

Defence Therapeutics (QB) compte actuellement 47 650 370 actions en circulation. La capitalisation boursière d'Defence Therapeutics (QB) est de US$13,02 million. Defence Therapeutics (QB) a un ratio cours/bénéfice (ratio PE) de -1.66.

DTCFF Dernières nouvelles

Plus de nouvelles

DEFENCE RETAINS CATO SMS TO ADVISE ON ITS  PHASE I CLINICAL TRIAL ON ACCUTOXTM FOR BREAST CANCER

 DEFENCE RETAINS CATO SMS TO ADVISE ON ITS  PHASE I CLINICAL TRIAL ON ACCUTOXTM FOR BREAST CANCER  Vancouver, BC, Canada, February 16th, 2022 -- InvestorsHub NewsWire Defence Therapeutics Inc...

16 Février 2022
InvestorsHub NewsWire

Defence's AccumTM-HPV vaccine formulation (AccuVAC-PT009) activates a 36-fold higher humoral response compared to Gardasil-9

  Defence's AccumTM-HPV vaccine formulation (AccuVAC-PT009) activates a 36-fold higher humoral response compared to Gardasil-9   Vancouver, BC, Canada, January 26th...

26 Janvier 2022
InvestorsHub NewsWire

DEFENCE THERAPEUTICS VACCINES AND PROGRAM DEVELOPMENT

Vancouver, BC, Canada -- November 30th 2021 -- InvestorsHub NewsWire -- Defence Therapeutics Inc. (CSE: DTC; FSE: DTC; USOTC: DTCFF) ("Defence" or the...

30 Novembre 2021
InvestorsHub NewsWire

DEFENCE THERAPEUTICS CANCER VACCINE ACCUVAC-D001 MANUFACTURING TARGETS MELANOMA AND BREAST CANCER

DEFENCE THERAPEUTICS CANCER VACCINE ACCUVAC-D001 MANUFACTURING TARGETS MELANOMA AND BREAST CANCER   Vancouver, BC, Canada -- November 23, 2021 -- InvestorsHub NewsWire...

23 Novembre 2021
InvestorsHub NewsWire

DEFENCE THERAPEUTICS APPOINTS DR. RIAM SHAMMAA TO ITS BOARD OF DIRECTORS

 DEFENCE THERAPEUTICS APPOINTS DR. RIAM SHAMMAA TO ITS BOARD OF DIRECTORS Vancouver, BC, Canada, November 9th, 2021 -- InvestorsHub NewsWire -- Defence Therapeutics Inc. CSE:DTC, USOTC:DTCFF...

09 Novembre 2021
InvestorsHub NewsWire

VACCINE RESULTS: DEFENCE THERAPEUTICS REPORTS SUCCESSFUL COMPLETION OF ITS COVID-19 VACCINE ACCUVAC-PT001 TOXICOLOGY STUDIES IN RABBITS

  VACCINE RESULTS: DEFENCE THERAPEUTICS REPORTS SUCCESSFUL COMPLETION OF ITS COVID-19 VACCINE ACCUVAC-PT001 TOXICOLOGY STUDIES IN RABBITS   Vancouver, BC, Canada, November...

03 Novembre 2021
InvestorsHub NewsWire

DEFENCE THERAPEUTICS ACCUMTM VARIANTS IN VITRO STUDY INCREASES THE POTENCY OF T-DERUXTECAN ADC BY 5-FOLD ON BREAST CANCER

  DEFENCE THERAPEUTICS ACCUMTM VARIANTS IN VITRO STUDY INCREASES THE POTENCY OF T-DERUXTECAN ADC BY 5-FOLD ON BREAST CANCER   Vancouver, BC, Canada, October 13th...

13 Octobre 2021
InvestorsHub NewsWire

DEFENCE THERAPEUTICS PREPARES FOR PHASE I TRIAL TO TEST ITS DC CANCER VACCINE, ACCUVAC-D002, AGAINST MELANOMA

    DEFENCE THERAPEUTICS PREPARES FOR PHASE I TRIAL TO TEST ITS DC CANCER VACCINE, ACCUVAC-D002, AGAINST MELANOMA Vancouver, BC, Canada, October 6th, 2021 -- InvestorsHub NewsWire -- Defence...

06 Octobre 2021
InvestorsHub NewsWire

DEFENCE THERAPEUTICS TO FINALIZE ITS OBJECTIVES TO INITIATE A PHASE I TRIAL AGAINST BREAST CANCER

 DEFENCE THERAPEUTICS TO FINALIZE ITS OBJECTIVES TO INITIATE A PHASE I TRIAL AGAINST BREAST CANCER Vancouver, BC, Canada, September 29th, 2021 - InvestorsHub NewsWire -- Defence Therapeutics Inc...

29 Septembre 2021
InvestorsHub NewsWire

DEFENCE THERAPEUTICS SUCCESSFULLY ENGINEERED AND TESTED A NOVEL INTRANASAL COVID-19 VACCINE FORMULATION IN ANIMALS

 DEFENCE THERAPEUTICS SUCCESSFULLY ENGINEERED AND TESTED A NOVEL INTRANASAL COVID-19 VACCINE FORMULATION IN ANIMALS Vancouver, BC, Canada, September 20th, 2021 -- InvestorsHub NewsWire -- Defence...

20 Septembre 2021
InvestorsHub NewsWire
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10000.4558000CS
40.0423410.24041019690.413460.45580.27321000.34333CS
120.0460611.24127495480.409740.45580.27326790.41217026CS
26-0.1942-29.87692307690.650.66070.27329050.49045093CS
52-1.1942-72.37575757581.651.7380.27328090.80631066CS
156-3.7942-89.27529411764.254.470.273210051.75341377CS
260-2.0442-81.7682.56.40780.273211862.81663998CS

DTCFF - Frequently Asked Questions (FAQ)

What is the current Defence Therapeutics (QB) share price?
The current share price of Defence Therapeutics (QB) is US$ 0,4558
How many Defence Therapeutics (QB) shares are in issue?
Defence Therapeutics (QB) has 47 650 370 shares in issue
What is the market cap of Defence Therapeutics (QB)?
The market capitalisation of Defence Therapeutics (QB) is USD 13,02M
What is the 1 year trading range for Defence Therapeutics (QB) share price?
Defence Therapeutics (QB) has traded in the range of US$ 0,2732 to US$ 1,738 during the past year
What is the PE ratio of Defence Therapeutics (QB)?
The price to earnings ratio of Defence Therapeutics (QB) is -1,66
What is the reporting currency for Defence Therapeutics (QB)?
Defence Therapeutics (QB) reports financial results in CAD
What is the latest annual profit for Defence Therapeutics (QB)?
The latest annual profit of Defence Therapeutics (QB) is CAD -13,19M
What is the registered address of Defence Therapeutics (QB)?
The registered address for Defence Therapeutics (QB) is 1680 - 200 BURRARD STREET, VANCOUVER, BRITISH COLUMBIA, V6C 3L6
What is the Defence Therapeutics (QB) website address?
The website address for Defence Therapeutics (QB) is www.defencetherapeutics.com
Which industry sector does Defence Therapeutics (QB) operate in?
Defence Therapeutics (QB) operates in the PHARMACEUTICAL PREPARATIONS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
DTEMFDitem Explorations (CE)
US$ 0,01
(999 900,00%)
1 000
RRMLFRoss River Minerals Inc (CE)
US$ 0,0089
(889 900,00%)
9,95k
FGHFFForte Group Holdings Inc (PK)
US$ 0,3833
(29 384,62%)
432
PRMDPrimeMD Inc (CE)
US$ 0,0002
(19 900,00%)
100
SDCCQSmileDirectClub Inc (CE)
US$ 0,0002
(19 900,00%)
392,07k
CDJMCarnegie Development Inc (CE)
US$ 0,000001
(-100,00%)
2,58k
RAHGFRoan Holdings Group Company Ltd (CE)
US$ 0,000001
(-99,99%)
200
UBMRFUrbanimmersive Inc (CE)
US$ 0,000001
(-99,97%)
1,5k
UNDRUnderSea Recovery Corporation (CE)
US$ 0,000001
(-99,90%)
55k
EICCFE Automotive Inc (CE)
US$ 0,0001
(-99,88%)
5,67k
PHILPHI Group Inc (PK)
US$ 0,0005
(0,00%)
562,38M
GRLFGreen Leaf Innovations Inc (PK)
US$ 0,0001
(0,00%)
284,6M
RDARRaadr Inc (PK)
US$ 0,0016
(-5,88%)
170,08M
HMBLHUMBL Inc (PK)
US$ 0,00085
(6,25%)
153,18M
CGACCode Green Apparel Corp (PK)
US$ 0,0004
(-11,11%)
113,22M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

USOTC
DTCFF
Defence Therapeutics (QB)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés